S&P 500   4,279.85 (-0.19%)
DOW   33,352.34 (-0.46%)
QQQ   359.93 (+0.46%)
AAPL   173.50 (+1.34%)
MSFT   317.99 (+0.71%)
META   305.25 (+1.68%)
GOOGL   133.45 (+1.98%)
AMZN   128.74 (+1.27%)
TSLA   248.11 (-0.84%)
NVDA   447.50 (+2.88%)
NIO   8.77 (-2.99%)
BABA   86.23 (-0.59%)
AMD   102.10 (-0.70%)
T   14.87 (-1.00%)
F   12.35 (-0.56%)
MU   67.91 (-0.18%)
CGC   0.78 (-0.43%)
GE   109.36 (-1.08%)
DIS   81.01 (-0.05%)
AMC   7.96 (-0.38%)
PFE   33.19 (+0.06%)
PYPL   58.96 (+0.86%)
NFLX   379.71 (+0.56%)
S&P 500   4,279.85 (-0.19%)
DOW   33,352.34 (-0.46%)
QQQ   359.93 (+0.46%)
AAPL   173.50 (+1.34%)
MSFT   317.99 (+0.71%)
META   305.25 (+1.68%)
GOOGL   133.45 (+1.98%)
AMZN   128.74 (+1.27%)
TSLA   248.11 (-0.84%)
NVDA   447.50 (+2.88%)
NIO   8.77 (-2.99%)
BABA   86.23 (-0.59%)
AMD   102.10 (-0.70%)
T   14.87 (-1.00%)
F   12.35 (-0.56%)
MU   67.91 (-0.18%)
CGC   0.78 (-0.43%)
GE   109.36 (-1.08%)
DIS   81.01 (-0.05%)
AMC   7.96 (-0.38%)
PFE   33.19 (+0.06%)
PYPL   58.96 (+0.86%)
NFLX   379.71 (+0.56%)
S&P 500   4,279.85 (-0.19%)
DOW   33,352.34 (-0.46%)
QQQ   359.93 (+0.46%)
AAPL   173.50 (+1.34%)
MSFT   317.99 (+0.71%)
META   305.25 (+1.68%)
GOOGL   133.45 (+1.98%)
AMZN   128.74 (+1.27%)
TSLA   248.11 (-0.84%)
NVDA   447.50 (+2.88%)
NIO   8.77 (-2.99%)
BABA   86.23 (-0.59%)
AMD   102.10 (-0.70%)
T   14.87 (-1.00%)
F   12.35 (-0.56%)
MU   67.91 (-0.18%)
CGC   0.78 (-0.43%)
GE   109.36 (-1.08%)
DIS   81.01 (-0.05%)
AMC   7.96 (-0.38%)
PFE   33.19 (+0.06%)
PYPL   58.96 (+0.86%)
NFLX   379.71 (+0.56%)
S&P 500   4,279.85 (-0.19%)
DOW   33,352.34 (-0.46%)
QQQ   359.93 (+0.46%)
AAPL   173.50 (+1.34%)
MSFT   317.99 (+0.71%)
META   305.25 (+1.68%)
GOOGL   133.45 (+1.98%)
AMZN   128.74 (+1.27%)
TSLA   248.11 (-0.84%)
NVDA   447.50 (+2.88%)
NIO   8.77 (-2.99%)
BABA   86.23 (-0.59%)
AMD   102.10 (-0.70%)
T   14.87 (-1.00%)
F   12.35 (-0.56%)
MU   67.91 (-0.18%)
CGC   0.78 (-0.43%)
GE   109.36 (-1.08%)
DIS   81.01 (-0.05%)
AMC   7.96 (-0.38%)
PFE   33.19 (+0.06%)
PYPL   58.96 (+0.86%)
NFLX   379.71 (+0.56%)
NASDAQ:ONTX

Onconova Therapeutics (ONTX) Earnings Date, Estimates & Call Transcripts

$0.72
+0.00 (+0.51%)
(As of 10:32 AM ET)
Compare
Today's Range
$0.72
▼
$0.79
50-Day Range
$0.72
▼
$1.04
52-Week Range
$0.62
▼
$1.49
Volume
13,320 shs
Average Volume
275,732 shs
Market Capitalization
$15.00 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$11.00
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media

Earnings Summary

Upcoming
Earnings Date
Nov. 13Estimated
Actual EPS
(Aug. 10)
-$0.20 Beat By $0.09
Consensus EPS
(Aug. 10)
-$0.29
Read Call Transcript
Listen to Call
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

ONTX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ONTX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Onconova Therapeutics Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20231($0.27)($0.27)($0.27)
Q2 20231($0.29)($0.29)($0.29)
Q3 20231($0.31)($0.31)($0.31)
Q4 20231($0.33)($0.33)($0.33)
FY 20234($1.20)($1.20)($1.20)

ONTX Earnings Date and Information

Onconova Therapeutics last posted its earnings results on August 10th, 2023. The biopharmaceutical company reported ($0.20) EPS for the quarter, topping analysts' consensus estimates of ($0.29) by $0.09. The firm had revenue of $0.06 million for the quarter, compared to analysts' expectations of $0.06 million. Onconova Therapeutics has generated ($1.00) earnings per share over the last year (($1.00) diluted earnings per share). Earnings for Onconova Therapeutics are expected to grow in the coming year, from ($1.10) to ($0.82) per share. Onconova Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 13th, 2023 based off prior year's report dates.

Onconova Therapeutics Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
11/13/2023
Estimated)		------- 
8/10/2023Q2 2023($0.29)($0.20)+$0.09($0.20)$0.06 million$0.06 million    
5/15/2023Q1 2023($0.27)($0.28)($0.01)($0.28)$0.06 million$0.06 million
3/16/2023Q4 2022($0.27)($0.26)+$0.01($0.26)$0.08 million$0.06 million
11/14/2022Q3 2022($0.21)($0.26)($0.05)($0.26)$0.06 million$0.06 million
8/11/2022Q2 2022($0.20)($0.19)+$0.01($0.19)$0.06 million$0.06 million    
5/11/2022Q1 2022($0.18)($0.20)($0.02)($0.20)$0.06 million$0.06 million    
3/17/2022Q4 2021-($0.16)($0.16)($0.16)$0.08 million$0.06 million    
11/11/2021Q3 2021($0.33)($0.22)+$0.11($0.22)$0.06 million$0.06 million    
8/12/2021Q2 2021($0.28)($0.27)+$0.01($0.27)$0.04 million$0.06 million    
5/17/2021Q1 2021($0.45)($0.30)+$0.15($0.02)$0.06 million$0.06 million  
3/11/2021Q4 2020($0.60)($0.45)+$0.15($0.03)$0.05 million$0.06 million  
11/12/2020Q3 2020($0.30)($0.45)($0.15)($0.03)$4.10 million$0.07 million  












Onconova Therapeutics Earnings - Frequently Asked Questions

When is Onconova Therapeutics's earnings date?

Onconova Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 13th, 2023 based off last year's report dates. Learn more on ONTX's earnings history.

Did Onconova Therapeutics beat their earnings estimates last quarter?

In the previous quarter, Onconova Therapeutics (NASDAQ:ONTX) reported ($0.20) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.29) by $0.09. Learn more on analysts' earnings estimate vs. ONTX's actual earnings.

How can I listen to Onconova Therapeutics's earnings conference call?

The conference call for Onconova Therapeutics's latest earnings report can be listened to online. Listen to Conference Call

How can I read Onconova Therapeutics's conference call transcript?

The conference call transcript for Onconova Therapeutics's latest earnings report can be read online. Read Transcript

How much revenue does Onconova Therapeutics generate each year?

Onconova Therapeutics (NASDAQ:ONTX) has a recorded annual revenue of $230,000.00.

How much profit does Onconova Therapeutics generate each year?

Onconova Therapeutics (NASDAQ:ONTX) has a recorded net income of -$18.96 million. ONTX has generated -$1.00 earnings per share over the last four quarters.

What is Onconova Therapeutics's EPS forecast for next year?

Onconova Therapeutics's earnings are expected to grow from ($1.10) per share to ($0.82) per share in the next year.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:ONTX) was last updated on 10/2/2023 by MarketBeat.com Staff

My Account -